| Name | VEGFR-2-IN-28 | 
|---|
| Description | VEGFR-2-IN-28 (compound 12c) is a potent VEGFR-2 inhibitor with IC50 value of 0.83 µM. VEGFR-2-IN-28 induces apoptosis and has anticancer activity[1]. | 
|---|---|
| Related Catalog | |
| Target | 
                                
                                 VEGFR-2:0.83 μM (IC50)  | 
                        
| In Vitro | VEGFR-2-IN-28 (compound 12c) (24 hours; MCF-7 cells) has anticancer activity with IC50 value of 16.50 µM[1]. VEGFR-2-IN-28 (compound 12c) (24 hours; MCF-7 cells) prompts pre-G1 apoptosis, cell growth cessation at G2/M phase and induces apoptosis via activation of caspase-3[1]. Apoptosis Analysis[1] Cell Line: MCF-7 cells Concentration: 16.50 µM Incubation Time: 24 hours Result: Induced apoptotic cells resulting in apoptosis percentage 28.41 %. Cell Cycle Analysis[1] Cell Line: MCF-7 cells Concentration: 16.50 µM Incubation Time: 24 hours Result: Increased in the percentage of cells at pre-G1 phase and at G2/M phase to 28.41% and 46.05%, respectively. Immunofluorescence[1] Cell Line: MCF-7 cells Concentration: 16.50 µM Incubation Time: 24 hours Result: Increased in the level of caspase-3. | 
| References | 
| Molecular Formula | C26H17N7O7 | 
|---|---|
| Molecular Weight | 539.46 |